cytosine has been researched along with 2019 Novel Coronavirus Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walsh, CT | 1 |
| Ma, J | 3 |
| Joehanes, R | 3 |
| Liu, C | 3 |
| Keshawarz, A | 3 |
| Hwang, SJ | 3 |
| Bui, H | 3 |
| Tejada, B | 3 |
| Sooda, M | 3 |
| Munson, PJ | 3 |
| Demirkale, CY | 3 |
| Courchesne, P | 3 |
| Heard-Costa, NL | 3 |
| Pitsillides, AN | 3 |
| Feolo, M | 3 |
| Sharopova, N | 3 |
| Vasan, RS | 3 |
| Huan, T | 3 |
| Levy, D | 3 |
| Blasco, H | 1 |
| Bessy, C | 1 |
| Plantier, L | 1 |
| Lefevre, A | 1 |
| Piver, E | 1 |
| Bernard, L | 1 |
| Marlet, J | 1 |
| Stefic, K | 1 |
| Benz-de Bretagne, I | 1 |
| Cannet, P | 1 |
| Lumbu, H | 1 |
| Morel, T | 1 |
| Boulard, P | 1 |
| Andres, CR | 1 |
| Vourc'h, P | 1 |
| Hérault, O | 1 |
| Guillon, A | 1 |
| Emond, P | 1 |
| Li, Y | 1 |
| Yang, X | 2 |
| Wang, N | 1 |
| Wang, H | 1 |
| Yin, B | 1 |
| Jiang, W | 1 |
| Ou, Z | 1 |
| Ouzounis, C | 1 |
| Wang, D | 1 |
| Sun, W | 1 |
| Li, J | 1 |
| Chen, W | 1 |
| Marlière, P | 1 |
| Danchin, A | 1 |
| Sadykov, M | 1 |
| Mourier, T | 1 |
| Guan, Q | 1 |
| Pain, A | 1 |
1 review available for cytosine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Covalent Catalytic Strategies for Enzymes That Modify RNA Molecules on their Tripartite Building Blocks.
Topics: Carbon; Catalysis; COVID-19; Cytosine; Glycosides; Guanine; Guanosine Triphosphate; Humans; Nucleosi | 2022 |
5 other studies available for cytosine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
Topics: Aged; Aged, 80 and over; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytosine; Ea | 2020 |
Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs.
Topics: Base Pair Mismatch; Betacoronavirus; Codon Usage; Coronavirus Infections; COVID-19; Cytosine; Databa | 2020 |
A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution.
Topics: COVID-19; Cytidine Triphosphate; Cytosine; Evolution, Molecular; Genome, Viral; Host-Pathogen Intera | 2020 |
Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction.
Topics: COVID-19; CpG Islands; Cytosine; Deamination; Humans; SARS-CoV-2 | 2021 |